RUSH University Cancer Center — Chicago, Illinois

RUSH University Cancer Center is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

RUSH University Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for RUSH University Cancer Center?

RUSH University Cancer Center has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has RUSH University Cancer Center conducted?

RUSH University Cancer Center has 1 clinical trials on record. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Is RUSH University Cancer Center accredited by Crixeo Health?

RUSH University Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about RUSH University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.